D-0507-2026 Class II Ongoing

Recalled by Wells Pharma Of Houston LLC — Houston, TX

FDA drug recall D-0507-2026 was initiated by Wells Pharma Of Houston LLC on Apr 1, 2026 and is designated Class II. Reason for recall: cGMP deviations. The recall status is ongoing. Affected quantity: 4975 syringes.

Recall details

Product Type
Drugs
Report Date
May 6, 2026
Initiation Date
Apr 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4975 syringes

Product description

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.

Reason for recall

cGMP deviations.

Distribution pattern

U.S. Nationwide.

Code information

120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0507-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0507-2026. Report a data issue: hello@regdatalab.com.